Home > Insider Trading > Filing (0001213900-20-043289)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1690080	180 Life Sciences Corp.	ATNF	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1033308	Marlene Krauss	30 Park Place, Suite 64B New York NY 10007		No	No	Yes	No
1706868	Kbl Iv Sponsor Llc	30 Park Place, Suite 64B New York NY 10007		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-12-17	12,103	$2.49	2,006,858	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-12-17	4,403	$2.44	2,018,961	No	4	S	Indirect	See footnote
Common Stock	Acquisiton	2020-12-16	334,608	$0.00	334,608	No	4	J	Direct
Common Stock	Disposition	2020-12-16	520,312	$0.00	2,023,364	No	4	J	Indirect	See footnote
Common Stock	Disposition	2020-12-15	17,877	$2.40	2,543,676	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-12-14	10,000	$2.45	2,561,553	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	J	Direct
No	4	J	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

The securities are held directly by KBL IV Sponsor LLC ("KBL Sponsor"). Dr. Marlene Krauss, the former Chief Executive Officer, and a former member of the Board of Directors, of the issuer, is the sole managing member of KBL Sponsor. Consequently, she may be deemed the beneficial owner of the securities of the issuer held by KBL Sponsor, and she has sole voting and dispositive control over such securities. Dr. Krauss disclaims beneficial ownership over any securities of the issuer owned by KBL Sponsor in which she does not have a pecuniary interest.
KBL Sponsor made a pro rata distribution for no consideration of an aggregate of 520,312 shares of the common stock of the issuer to its members on December 16, 2020.
Represents 334,608 shares of the issuer's common stock that were received by Dr. Krauss in a pro rata distribution made by KBL Sponsor to its members on December 16, 2020. In prior reports, Dr. Krauss reported indirect beneficial ownership of all of the shares of the issuer's common stock held by KBL Sponsor.